Pivot Pharmaceutical - Egypt company information, Employees & Contact Information

Havas Lynx presses pharma to pivot from 'selling to serving' to confront health misinformation Fierce Pharma

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease PR Newswire

Boehringer Ingelheim, Novartis latest to bypass middleman in pharma's DTC rush FirstWord Pharma

Teva’s CEO shares ‘Pivot to Growth’ progress Fierce Pharma

After putting BioNTech on track for oncology pivot, chief strategist exits FirstWord Pharma

Sustainability Pivot: Pharma Companies Are Shifting To Cleaner Practices Business Today

Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M Fierce Pharma

Rocket ditches blood disorder gene therapy in ongoing pipeline pivot Pharmaceutical Technology

Friday Five – Lilly's obesity oral could eat up competition, pill penalty pivot, tariff talk…and more FirstWord Pharma

Supreme Group buys Pivot Design, bringing agency takeover tally to 9 in 18 months Fierce Pharma

Rising Stars: How Arc Bio’s Kareem Clark uses his neuroscience background to help clients communicate Fierce Pharma

Novartis puts $1B cash on the table for PTC's Huntington's disease programme FirstWord Pharma

'Land mines everywhere': How pharma communications keep up under a political spotlight Fierce Pharma

Angela Hwang on her pivot from Big Pharma to biotech Fierce Pharma

GSK telegraphs 150 layoffs amid plan to transfer vaccine manufacturing from Massachusetts site Fierce Pharma

Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase Fierce Pharma

Aadi Bioscience takes flight with new moniker: Whitehawk Therapeutics Fierce Pharma

FDA lays out stricter COVID vaccine policy in pivot from 'one-size-fits-all' approach Fierce Pharma

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit Fierce Pharma

A year on, Teva CEO Richard Francis celebrates progress in 'Pivot to Growth' plan Fierce Pharma

The ability to pivot will be ‘key’ as pharma’s tariff threat looms Pharma Voice

Supreme Group continues acquisition streak with rare disease agency Pivot Design Medical Marketing and Media

AcelRx becomes Talphera, adopting new name to reflect pain pivot Fierce Pharma

Teva's new CEO Richard Francis lays out his 'pivot to growth' strategy Fierce Pharma

Sanofi CEO Paul Hudson's new 'Play to Win' pivot sends stock plunging Fierce Pharma

With DTC ads under fire, pharma companies need to pivot Pharma Voice

Big Pharma’s New Chapter: M&A, Metabolism &the Outsourcing Boom Contract Pharma

Teva's refresh under new CEO Richard Francis moves into year 2 as Austedo, Ajovy and generics gain steam Fierce Pharma

ElevAAte and the push for East Asian American leaders in biopharma Fierce Pharma

Uzbekistan’s Pharma Pivot: Strategic Gains or Growing Dependence on China The Times Of Central Asia

Kymera stakes future on immunology after oncology pivot FirstWord Pharma

As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model Fierce Pharma

Teetering on the edge, Midatech plots pivot beyond drug delivery platform with Bioasis buyout Fierce Pharma

Takeda winds down manufacturing and R&D operations in Austria after gene therapy pivot, plots 190 layoffs Fierce Pharma

Amid strategic pivot, 2seventy bio plots comeback for BMS-partnered CAR-T Abecma Fierce Pharma

Teva's generics and biosimilars fuel another booming quarter Fierce Pharma

After pivot, Agios names Alexion vet Goff its next CEO as Fouse transitions to board chair Fierce Pharma

Bristol Myers charts 500-plus new layoffs in New Jersey following expanded cost-savings drive Fierce Pharma

Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity Health Policy Watch

TNF Pharmaceuticals surges 16% on crypto pivot and LightSolver partnership Mugglehead Magazine

In continuing its transformation, Teva confirms plan to sell off API business Fierce Pharma

Boosted by $19M equity package, Teva's Richard Francis joins upper echelons of pharma CEO pay ranks Fierce Pharma

Galapagos mulls sale of cell therapy unit in latest strategic rethink FirstWord Pharma

Teva, forging ahead with new strategy, inks biosimilar deal with Spain's mAbxience Fierce Pharma

GSK and Spero's oral antibiotic succeeds in pivotal UTI study FirstWord Pharma

Teva weighs sale of $2B API business as CEO Richard Francis embarks on 'Pivot to Growth' strategy: reports Fierce Pharma

In strategic pivot under new CEO Richard Francis, Teva plots cuts to its generics portfolio Fierce Pharma

Fierce Pharma Asia—Big Pharma’s China layoffs, CSL's site closure and Kyowa Kirin's oncology deal Fierce Pharma

Teva taps Matthew Shields to oversee manufacturing and supply division amid company revamp Fierce Pharma

Biogen retains biosimilars as Eisai-partnered Leqembi plows ahead amid business pivot Fierce Pharma

After layoffs and R&D pivot, cash-strapped VBL sells gene therapy manufacturing plant Fierce Pharma

Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio Fierce Pharma

Henlius CEO scouts for US PD-1 partner amid Fosun unit's pivot to innovative drugs from biosimilars Fierce Pharma

Emergent to lay off 400 staffers, eliminate executive position in pivot away from contract manufacturing Fierce Pharma

Sarepta, with $1B in debts due in 2027, weighs efficiency measures Fierce Pharma

With Austedo rolling and Uzedy launch getting started, Teva shows early signs of a turnaround Fierce Pharma

Teva CEO Richard Francis poaches business development head Angus Grant from BeiGene Fierce Pharma

Ori doubles down on Charles River collaboration with promising new data on its automated cell therapy platform Fierce Pharma

Breakingviews - European pharma’s growth prescription: pivot to US Reuters

PTC's Novartis-partnered Huntington's drug disappoints in mid-stage data reveal FirstWord Pharma

Trump's pharma tariff pivot hits Australian and India drugmakers Nikkei Asia

Most influential people in biopharma—the scientists Fierce Pharma

Fierce Pharma Asia—Eisai's oncology unit cut; WuXi, Samsung expansions; BeiGene, Novartis' PD-1 pivot Fierce Pharma

Ferring halts all shipments of flagship fertility drug Menopur after third-party manufacturing pivot Fierce Pharma

Jazz grows cannabinoid manufacturing ambitions with new $100M plant Fierce Pharma

Scynexis plans to cut 40% of staff and license its approved antifungal in pivot to R&D Fierce Pharma

Pharma deal values plummet 56% as COVID-19 disrupts resources: report Fierce Pharma

Pharma industry needs to pivot beyond generics | Policy Circle policycircle.org

Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny Fierce Pharma

Takeda unveils new Boston R&D manufacturing center for cell therapy pipeline push Fierce Pharma

How to launch a drug in a pandemic? Here's how 4 drugmakers are using digital tools and fast footwork to do just that Fierce Pharma

Lonza to Sell Specialty Ingredients Division for $4.7 Billion, Pivot to Pharma BioSpace

AI, machine learning to help Indian pharma industry to pivot on innovation Business Standard

Specialty chemical firms pivot to pharma Mint

Indian pharma industry's big pivot: Report reveals sector transitioning from generics to innovation Business Today

Silo Pharma stock jumps 22% as Fireblocks joins crypto treasury pivot Crypto News